Portfolio

LSP HEF 2

Investments range between EUR 10 million and EUR 30 million

LSP HEF 2 (Health Economic Fund) seeks to invest in health care technology companies in late-stage development or early-stage commercialization. Products or technologies need to have the potential to improve the quality of healthcare and lower the cost of care at the same time. LSP HEF 2’s geographical focus is primarily Europe and the US.

Rudy Dekeyser Partner and Head of Health Economic Funds
Send email

LSP Advisory B.V.
Johannes Vermeerplein 9
1071 DV Amsterdam, the Netherlands

Company Registration Number: 34296447

LSP Advisory B.V. is an alternative investment fund manager authorized and regulated in accordance with laws of the Netherlands.

Fast facts

  • Status
    Active
  • Launch
    2018
  • Size
    EUR 280 m
  • SFDR classification
    Art. 8

Investment advisory committee

  • Chairperson
    Andre Olijslager
  • Fundamental VR
  • Xeltis
  • Perfuze
  • Nobi
  • DOTS Technology
  • iStar Medical
  • Neurent Medical
  • One Projects
  • Atlantic Therapeutics
  • Lumeon
  • Endotronix
  • Vicentra